Sleep-Disordered Breathing

Neurologic Clinics

Volumn 30, Issue 4, 2012, Pages 1095-1136

  Ioachimescu, Octavian C ^a   Collop, Nancy A ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Central sleep apnea; Obstructive sleep apnea; Sleep disordered breathing; Snoring

Indexed keywords

ACETAZOLAMIDE; AMINOPHYLLINE; AMPHETAMINE; ARMODAFINIL; ATENOLOL; CILAZAPRIL; DECONGESTIVE AGENT; ESTROGEN; ISRADIPINE; MEDROXYPROGESTERONE; METHYLPHENIDATE; METHYLXANTHINE; METOPROLOL; MODAFINIL; NALOXONE; NALTREXONE; OPIATE; PLACEBO; PROGESTERONE; PROPRANOLOL; RAMIPRIL; SEROTONIN 3 ANTAGONIST; THEOPHYLLINE; TRIAZOLAM; ZOLPIDEM;

ANOREXIA; APNEA; BEHAVIOR THERAPY; BODY MASS; CENTRAL SLEEP APNEA SYNDROME; CLINICAL FEATURE; CLINICAL TRIAL; COUGHING; DAYTIME SOMNOLENCE; DIARRHEA; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; HEADACHE; HEALTH HAZARD; HUMAN; HYPERTENSION; HYPOPNEA INDEX; INSOMNIA; LIFESTYLE MODIFICATION; NARCOLEPSY; NAUSEA; NOSE OBSTRUCTION; OBESITY; OBESITY HYPOVENTILATION SYNDROME; OXYGEN SATURATION; OXYGEN THERAPY; PATHOGENESIS; PHYSICAL EXAMINATION; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; QUALITY OF LIFE; RADIOFREQUENCY ABLATION; REVIEW; RISK FACTOR; SLEEP DISORDERED BREATHING; SLEEP PATTERN; SNORING; SOMNOLENCE; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; TREATMENT INDICATION; UPPER AIRWAY RESISTANCE SYNDROME; VOMITING; XEROSTOMIA;

DYSPNEA; HUMANS; MALE; MIDDLE AGED; OBESITY; POLYSOMNOGRAPHY; SLEEP APNEA SYNDROMES; SNORING;

EID: 84867907393     PISSN: 07338619     EISSN: 15579875     Source Type: Journal    
DOI: 10.1016/j.ncl.2012.08.003     Document Type: Review

References (300)

1. Iber C., Ancoli-Israel S., Chesson A., et al. The AASM manual for the scoring of sleep and associated events - rules, terminology and technical specifications 2007, American Academy of Sleep Medicine, Westchester (IL). 1st edition.
2. Kotha K., Ioachimescu O.C. Obstructive Sleep Apnea. Contemporary Sleep Medicine (for Physicians, online publication, 1st edition) 2011, Bentham Science Publishers, Sharjah (UAE). O.C. Ioachimescu (Ed.).
3. Guilleminault C., Tilkian A., Dement W.C. The sleep apnea syndromes. Annu Rev Med 1976, 27:465-484.
4. Epstein L.J., Kristo D., Strollo P.J., et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med 2009, 5(3):263-276.
5. Gupta R.M., Parvizi J., Hanssen A.D., et al. Postoperative complications in patients with obstructive sleep apnea syndrome undergoing hip or knee replacement: a case-control study. Mayo Clin Proc 2001, 76(9):897-905.
6. Kaw R., Golish J., Ghamande S., et al. Incremental risk of obstructive sleep apnea on cardiac surgical outcomes. J Cardiovasc Surg (Torino) 2006, 47(6):683-689.
7. Peppard P.E., Young T., Palta M., et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000, 342(19):1378-1384.
8. Schafer H., Koehler U., Ewig S., et al. Obstructive sleep apnea as a risk marker in coronary artery disease. Cardiology 1999, 92(2):79-84.
9. Peker Y., Kraiczi H., Hedner J., et al. An independent association between obstructive sleep apnoea and coronary artery disease. Eur Respir J 1999, 14(1):179-184.
10. Gami A.S., Howard D.E., Olson E.J., et al. Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 2005, 352(12):1206-1214.
11. Arzt M., Young T., Finn L., et al. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 2005, 172(11):1447-1451.
12. Yaggi H.K., Concato J., Kernan W.N., et al. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005, 353(19):2034-2041.
13. Krieger J., Sforza E., Apprill M., et al. Pulmonary hypertension, hypoxemia, and hypercapnia in obstructive sleep apnea patients. Chest 1989, 96(4):729-737.
14. Ambrosetti M., Lucioni A., Ageno W., et al. Is venous thromboembolism more frequent in patients with obstructive sleep apnea syndrome?. J Thromb Haemost 2004, 2(10):1858-1860.
15. Jean-Louis G., Zizi F., Clark L.T., et al. Obstructive sleep apnea and cardiovascular disease: role of the metabolic syndrome and its components. J Clin Sleep Med 2008, 4(3):261-272.
16. Punjabi N.M., Shahar E., Redline S., et al. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 2004, 160(6):521-530.
17. Marin J.M., Carrizo S.J., Vicente E., et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005, 365(9464):1046-1053.
18. Nieto F.J., Young T.B., Lind B.K., et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000, 283(14):1829-1836.
19. Peppard P.E., Young T., Palta M., et al. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 2000, 284(23):3015-3021.
20. Young T., Peppard P.E., Gottlieb D.J. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002, 165(9):1217-1239.
21. Moyer C.A., Sonnad S.S., Garetz S.L., et al. Quality of life in obstructive sleep apnea: a systematic review of the literature. Sleep Med 2001, 2(6):477-491.
22. Engleman H.M., Douglas N.J. Sleep, driving and the workplace. Clin Med 2005, 5(2):113-117.
23. Sassani A., Findley L.J., Kryger M., et al. Reducing motor-vehicle collisions, costs, and fatalities by treating obstructive sleep apnea syndrome. Sleep 2004, 27(3):453-458.
24. Lindberg E., Carter N., Gislason T., et al. Role of snoring and daytime sleepiness in occupational accidents. Am J Respir Crit Care Med 2001, 164(11):2031-2035.
25. Saunamaki T., Jehkonen M. A review of executive functions in obstructive sleep apnea syndrome. Acta Neurol Scand 2007, 115(1):1-11.
26. Marshall N.S., Wong K.K., Liu P.Y., et al. Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep 2008, 31(8):1079-1085.
27. Young T., Finn L., Peppard P.E., et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 2008, 31(8):1071-1078.
28. Young T., Palta M., Dempsey J., et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993, 328(17):1230-1235.
29. Bixler E.O., Vgontzas A.N., Ten H.T., et al. Effects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med 1998, 157(1):144-148.
30. Bixler E.O., Vgontzas A.N., Lin H.M., et al. Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med 2001, 163(3 Pt 1):608-613.
31. Ip M.S., Lam B., Lauder I.J., et al. A community study of sleep-disordered breathing in middle-aged Chinese men in Hong Kong. Chest 2001, 119(1):62-69.
32. Ip M.S., Lam B., Tang L.C., et al. A community study of sleep-disordered breathing in middle-aged Chinese women in Hong Kong: prevalence and gender differences. Chest 2004, 125(1):127-134.
33. American Academy of Sleep Medicine Task Force Report. Sleep related breathing disorders in adults:recommendations for syndrome, definition and measurement techniques in clinical research. Sleep 1999, 22:667-689.
34. Santos-Silva R., Tufik S., Conway S.G., et al. Sao Paulo epidemiologic sleep study: rationale, design, sampling, and procedures. Sleep Med 2009, 10(6):679-685.
35. Stradling J.R., Crosby J.H. Predictors and prevalence of obstructive sleep apnoea and snoring in 1001 middle aged men. Thorax 1991, 46(2):85-90.
36. Jennum P., Sjol A. Epidemiology of snoring and obstructive sleep apnoea in a Danish population, age 30-60. J Sleep Res 1992, 1(4):240-244.
37. Punjabi N.M. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc 2008, 5(2):136-143.
38. Bearpark H., Elliott L., Grunstein R., et al. Snoring and sleep apnea. A population study in Australian men. Am J Respir Crit Care Med 1995, 151(5):1459-1465.
39. Duran J., Esnaola S., Rubio R., et al. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med 2001, 163(3 Pt 1):685-689.
40. Udwadia Z.F., Doshi A.V., Lonkar S.G., et al. Prevalence of sleep-disordered breathing and sleep apnea in middle-aged urban Indian men. Am J Respir Crit Care Med 2004, 169(2):168-173.
41. Puvanendran K., Goh K.L. From snoring to sleep apnea in a Singapore population. Sleep Res Online 1999, 2(1):11-14.
42. Gislason T., Almqvist M., Eriksson G., et al. Prevalence of sleep apnea syndrome among Swedish men-an epidemiological study. J Clin Epidemiol 1988, 41(6):571-576.
43. Tishler P.V., Larkin E.K., Schluchter M.D., et al. Incidence of sleep-disordered breathing in an urban adult population: the relative importance of risk factors in the development of sleep-disordered breathing. JAMA 2003, 289(17):2230-2237.
44. Young T., Evans L., Finn L., et al. Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women. Sleep 1997, 20(9):705-706.
45. Kapur V., Strohl K.P., Redline S., et al. Underdiagnosis of sleep apnea syndrome in U.S. communities. Sleep Breath 2002, 6(2):49-54.
46. Foley D.J., Monjan A.A., Brown S.L., et al. Sleep complaints among elderly persons: an epidemiologic study of three communities. Sleep 1995, 18(6):425-432.
47. Ancoli-Israel S., Kripke D.F., Klauber M.R., et al. Sleep-disordered breathing in community-dwelling elderly. Sleep 1991, 14(6):486-495.
48. Young T., Skatrud J., Peppard P.E. Risk factors for obstructive sleep apnea in adults. JAMA 2004, 291(16):2013-2016.
49. Obesity and overweight, 2006. Available at:. 2006. Accessed May, 2012. http://www.who.int/mediacentre/factsheets/fs311/en/index.html.
50. Obesity in US adults: 2007. Available at:. 2007. Accessed May, 2012. http://www.obesity.org/statistics/.
51. Katz I., Stradling J., Slutsky A.S., et al. Do patients with obstructive sleep apnea have thick necks?. Am Rev Respir Dis 1990, 141(5 Pt 1):1228-1231.
52. Grunstein R., Wilcox I., Yang T.S., et al. Snoring and sleep apnoea in men: association with central obesity and hypertension. Int J Obes Relat Metab Disord 1993, 17(9):533-540.
53. Davies R.J., Stradling J.R. The relationship between neck circumference, radiographic pharyngeal anatomy, and the obstructive sleep apnoea syndrome. Eur Respir J 1990, 3(5):509-514.
54. Davies R.J., Ali N.J., Stradling J.R. Neck circumference and other clinical features in the diagnosis of the obstructive sleep apnoea syndrome. Thorax 1992, 47(2):101-105.
55. Hoffstein V., Mateika S. Differences in abdominal and neck circumferences in patients with and without obstructive sleep apnoea. Eur Respir J 1992, 5(4):377-381.
56. Levinson P.D., McGarvey S.T., Carlisle C.C., et al. Adiposity and cardiovascular risk factors in men with obstructive sleep apnea. Chest 1993, 103(5):1336-1342.
57. Millman R.P., Carlisle C.C., McGarvey S.T., et al. Body fat distribution and sleep apnea severity in women. Chest 1995, 107(2):362-366.
58. Shelton K.E., Woodson H., Gay S., et al. Pharyngeal fat in obstructive sleep apnea. Am Rev Respir Dis 1993, 148(2):462-466.
59. Shinohara E., Kihara S., Yamashita S., et al. Visceral fat accumulation as an important risk factor for obstructive sleep apnoea syndrome in obese subjects. J Intern Med 1997, 241(1):11-18.
60. Ferini-Strambi L., Zucconi M., Palazzi S., et al. Snoring and nocturnal oxygen desaturations in an Italian middle-aged male population. Epidemiologic study with an ambulatory device. Chest 1994, 105(6):1759-1764.
61. Newman A.B., Nieto F.J., Guidry U., et al. Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol 2001, 154(1):50-59.
62. Olson L.G., King M.T., Hensley M.J., et al. A community study of snoring and sleep-disordered breathing. Prevalence. Am J Respir Crit Care Med 1995, 152(2):711-716.
63. Jennum P., Hein H.O., Suadicani P., et al. Cardiovascular risk factors in snorers. A cross-sectional study of 3,323 men aged 54 to 74 years: the Copenhagen Male Study. Chest 1992, 102(5):1371-1376.
64. Jennum P., Sjol A. Snoring, sleep apnoea and cardiovascular risk factors: the MONICA II study. Int J Epidemiol 1993, 22(3):439-444.
65. Schmidt-Nowara W.W., Coultas D.B., Wiggins C., et al. Snoring in a Hispanic-American population. Risk factors and association with hypertension and other morbidity. Arch Intern Med 1990, 150(3):597-601.
66. Frey W.C., Pilcher J. Obstructive sleep-related breathing disorders in patients evaluated for bariatric surgery. Obes Surg 2003, 13(5):676-683.
67. O'Keeffe T., Patterson E.J. Evidence supporting routine polysomnography before bariatric surgery. Obes Surg 2004, 14(1):23-26.
68. Bae C., Schauer P., Chand B., et al. Physical examination predictors of obstructive sleep apnea in bariatric surgery candidates. Sleep 2007, 30(Suppl):A207.
69. Bliwise D.L. Epidemiology of age-dependence in sleep disordered breathing (SDB) in old age: the Bay Area Sleep Cohort (BASC). Sleep Med Clin 2009, 4(1):57-64.
70. Jennum P., Riha R.L. Epidemiology of sleep apnoea/hypopnoea syndrome and sleep-disordered breathing. Eur Respir J 2009, 33(4):907-914.
71. Flemons W.W. Clinical practice. Obstructive sleep apnea. N Engl J Med 2002, 347(7):498-504.
72. Franklin K.A., Holmgren P.A., Jonsson F., et al. Snoring, pregnancy-induced hypertension, and growth retardation of the fetus. Chest 2000, 117(1):137-141.
73. Guilleminault C., Querra-Salva M., Chowdhuri S., et al. Normal pregnancy, daytime sleeping, snoring and blood pressure. Sleep Med 2000, 1(4):289-297.
74. Pillar G., Lavie P. Assessment of the role of inheritance in sleep apnea syndrome. Am J Respir Crit Care Med 1995, 151(3 Pt 1):688-691.
75. Mathur R., Douglas N.J. Family studies in patients with the sleep apnea-hypopnea syndrome. Ann Intern Med 1995, 122(3):174-178.
76. Redline S., Tishler P.V., Tosteson T.D., et al. The familial aggregation of obstructive sleep apnea. Am J Respir Crit Care Med 1995, 151(3 Pt 1):682-687.
77. Ovchinsky A., Rao M., Lotwin I., et al. The familial aggregation of pediatric obstructive sleep apnea syndrome. Arch Otolaryngol Head Neck Surg 2002, 128(7):815-818.
78. Carmelli D., Bliwise D.L., Swan G.E., et al. Genetic factors in self-reported snoring and excessive daytime sleepiness: a twin study. Am J Respir Crit Care Med 2001, 164(6):949-952.
79. Jennum P., Hein H.O., Suadicani P., et al. Snoring, family history, and genetic markers in men. The Copenhagen Male Study. Chest 1995, 107(5):1289-1293.
80. Riha R.L., Gislasson T., Diefenbach K. The phenotype and genotype of adult obstructive sleep apnoea/hypopnoea syndrome. Eur Respir J 2009, 33(3):646-655.
81. Palmer L.J., Buxbaum S.G., Larkin E., et al. A whole-genome scan for obstructive sleep apnea and obesity. Am J Hum Genet 2003, 72(2):340-350.
82. Palmer L.J., Buxbaum S.G., Larkin E.K., et al. Whole genome scan for obstructive sleep apnea and obesity in African-American families. Am J Respir Crit Care Med 2004, 169(12):1314-1321.
83. Patel S.R., Larkin E.K., Redline S. Shared genetic basis for obstructive sleep apnea and adiposity measures. Int J Obes (Lond) 2008, 32(5):795-800.
84. Schwab R.J., Pasirstein M., Kaplan L., et al. Family aggregation of upper airway soft tissue structures in normal subjects and patients with sleep apnea. Am J Respir Crit Care Med 2006, 173(4):453-463.
85. Li K.K., Powell N.B., Kushida C., et al. A comparison of Asian and white patients with obstructive sleep apnea syndrome. Laryngoscope 1999, 109(12):1937-1940.
86. Lam B., Ip M.S., Tench E., et al. Craniofacial profile in Asian and white subjects with obstructive sleep apnoea. Thorax 2005, 60(6):504-510.
87. Wetter D.W., Young T.B., Bidwell T.R., et al. Smoking as a risk factor for sleep-disordered breathing. Arch Intern Med 1994, 154(19):2219-2224.
88. Lavie L., Lavie P. Smoking interacts with sleep apnea to increase cardiovascular risk. Sleep Med 2008, 9(3):247-253.
89. Mitler M.M., Dawson A., Henriksen S.J., et al. Bedtime ethanol increases resistance of upper airways and produces sleep apneas in asymptomatic snorers. Alcohol Clin Exp Res 1988, 12(6):801-805.
90. Berry R.B., Bonnet M.H., Light R.W. Effect of ethanol on the arousal response to airway occlusion during sleep in normal subjects. Am Rev Respir Dis 1992, 145(2 Pt 1):445-452.
91. Scanlan M.F., Roebuck T., Little P.J., et al. Effect of moderate alcohol upon obstructive sleep apnoea. Eur Respir J 2000, 16(5):909-913.
92. Young T., Finn L., Kim H. Nasal obstruction as a risk factor for sleep-disordered breathing. The University of Wisconsin Sleep and Respiratory Research Group. J Allergy Clin Immunol 1997, 99(2):S757-S762.
93. McNicholas W.T., Tarlo S., Cole P., et al. Obstructive apneas during sleep in patients with seasonal allergic rhinitis. Am Rev Respir Dis 1982, 126(4):625-628.
94. Grunstein R.R., Ho K.Y., Sullivan C.E. Sleep apnea in acromegaly. Ann Intern Med 1991, 115(7):527-532.
95. Lanfranco F., Motta G., Minetto M.A., et al. Neuroendocrine alterations in obese patients with sleep apnea syndrome. Int J Endocrinol 2010, 2010:474518.
96. Fatti L.M., Scacchi M., Pincelli A.I., et al. Prevalence and pathogenesis of sleep apnea and lung disease in acromegaly. Pituitary 2001, 4(4):259-262.
97. Mestron A., Webb S.M., Astorga R., et al. Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA). Eur J Endocrinol 2004, 151(4):439-446.
98. Winkelman J.W., Goldman H., Piscatelli N., et al. Are thyroid function tests necessary in patients with suspected sleep apnea?. Sleep 1996, 19(10):790-793.
99. Fogel R.B., Malhotra A., Pillar G., et al. Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 2001, 86(3):1175-1180.
100. Vgontzas A.N., Legro R.S., Bixler E.O., et al. Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. J Clin Endocrinol Metab 2001, 86(2):517-520.
101. Schneider B.K., Pickett C.K., Zwillich C.W., et al. Influence of testosterone on breathing during sleep. J Appl Physiol 1986, 61(2):618-623.
102. Liu P.Y., Yee B., Wishart S.M., et al. The short-term effects of high-dose testosterone on sleep, breathing, and function in older men. J Clin Endocrinol Metab 2003, 88(8):3605-3613.
103. Haponik E.F., Smith P.L., Bohlman M.E., et al. Computerized tomography in obstructive sleep apnea. Correlation of airway size with physiology during sleep and wakefulness. Am Rev Respir Dis 1983, 127(2):221-226.
104. Schwab R.J., Gefter W.B., Hoffman E.A., et al. Dynamic upper airway imaging during awake respiration in normal subjects and patients with sleep disordered breathing. Am Rev Respir Dis 1993, 148(5):1385-1400.
105. Schwab R.J., Gefter W.B., Pack A.I., et al. Dynamic imaging of the upper airway during respiration in normal subjects. J Appl Physiol 1993, 74(4):1504-1514.
106. Schwab R.J., Gupta K.B., Gefter W.B., et al. Upper airway and soft tissue anatomy in normal subjects and patients with sleep-disordered breathing. Significance of the lateral pharyngeal walls. Am J Respir Crit Care Med 1995, 152(5 Pt 1):1673-1689.
107. Remmers J.E., Anch A.M., deGroot W.J., et al. Oropharyngeal muscle tone in obstructive sleep apnea before and after strychnine. Sleep 1980, 3(3-4):447-453.
108. Isono S., Feroah T.R., Hajduk E.A., et al. Interaction of cross-sectional area, driving pressure, and airflow of passive velopharynx. J Appl Physiol 1997, 83(3):851-859.
109. White D.P. The pathogenesis of obstructive sleep apnea: advances in the past 100 years. Am J Respir Cell Mol Biol 2006, 34(1):1-6.
110. Fogel R.B., Malhotra A., White D.P. Sleep. 2: pathophysiology of obstructive sleep apnoea/hypopnoea syndrome. Thorax 2004, 59(2):159-163.
111. Dempsey J.A., Veasey S.C., Morgan B.J., et al. Pathophysiology of sleep apnea. Physiol Rev 2010, 90(1):47-112.
112. Wenner J.B., Cheema R., Ayas N.T. Clinical manifestations and consequences of obstructive sleep apnea. J Cardiopulm Rehabil Prev 2009, 29(2):76-83.
113. Cluydts R., De V.E., Verstraeten E., et al. Daytime sleepiness and its evaluation. Sleep Med Rev 2002, 6(2):83-96.
114. Ramachandran S.K., Josephs L.A. A meta-analysis of clinical screening tests for obstructive sleep apnea. Anesthesiology 2009, 110(4):928-939.
115. Netzer N.C., Stoohs R.A., Netzer C.M., et al. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 1999, 131(7):485-491.
116. Nuckton T.J., Glidden D.V., Browner W.S., et al. Physical examination: mallampati score as an independent predictor of obstructive sleep apnea. Sleep 2006, 29(7):903-908.
117. Waite P.D. Obstructive sleep apnea: a review of the pathophysiology and surgical management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998, 85(4):352-361.
118. Ioachimescu OC. The diagnosis and severity of obstructive sleep apnea (OSA): a comprehensive analysis of different predictive models. 21st Annual Meeting of the Associated Professional Sleep Societies. Sleep 2007;30(Suppl):A165.
119. Netzer N., Eliasson A.H., Netzer C., et al. Overnight pulse oximetry for sleep-disordered breathing in adults: a review. Chest 2001, 120(2):625-633.
120. ICSD-2-The international classification of sleep disorders-diagnostic and coding manual 2005, American Academy of Sleep Medicine, Westchester (IL). 2nd edition.
121. Collop N.A., Anderson W.M., Boehlecke B., et al. Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. Portable monitoring task force of the American Academy of Sleep Medicine. J Clin Sleep Med 2007, 3(7):737-747.
122. Littner M.R., Kushida C., Wise M., et al. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep 2005, 28(1):113-121.
123. Arand D., Bonnet M., Hurwitz T., et al. The clinical use of the MSLT and MWT. Sleep 2005, 28(1):123-144.
124. Bonnet M.H. ACNS clinical controversy: MSLT and MWT have limited clinical utility. J Clin Neurophysiol 2006, 23(1):50-58.
125. Bonnet M.H., Arand D.L. We are chronically sleep deprived. Sleep 1995, 18(10):908-911.
126. Guilleminault C., Rosekind M. The arousal threshold: sleep deprivation, sleep fragmentation, and obstructive sleep apnea syndrome. Bull Eur Physiopathol Respir 1981, 17(3):341-349.
127. White D.P., Douglas N.J., Pickett C.K., et al. Sleep deprivation and the control of ventilation. Am Rev Respir Dis 1983, 128(6):984-986.
128. Bowes G., Woolf G.M., Sullivan C.E., et al. Effect of sleep fragmentation on ventilatory and arousal responses of sleeping dogs to respiratory stimuli. Am Rev Respir Dis 1980, 122(6):899-908.
129. Harman E.M., Wynne J.W., Block A.J. The effect of weight loss on sleep-disordered breathing and oxygen desaturation in morbidly obese men. Chest 1982, 82(3):291-294.
130. Kajaste S., Brander P.E., Telakivi T., et al. A cognitive-behavioral weight reduction program in the treatment of obstructive sleep apnea syndrome with or without initial nasal CPAP: a randomized study. Sleep Med 2004, 5(2):125-131.
131. Schwartz A.R., Gold A.R., Schubert N., et al. Effect of weight loss on upper airway collapsibility in obstructive sleep apnea. Am Rev Respir Dis 1991, 144(3 Pt 1):494-498.
132. Smith P.L., Gold A.R., Meyers D.A., et al. Weight loss in mildly to moderately obese patients with obstructive sleep apnea. Ann Intern Med 1985, 103(6 Pt 1):850-855.
133. Suratt P.M., McTier R.F., Findley L.J., et al. Changes in breathing and the pharynx after weight loss in obstructive sleep apnea. Chest 1987, 92(4):631-637.
134. Buchwald H., Avidor Y., Braunwald E., et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004, 292(14):1724-1737.
135. Fernandez A.Z., DeMaria E.J., Tichansky D.S., et al. Experience with over 3,000 open and laparoscopic bariatric procedures: multivariate analysis of factors related to leak and resultant mortality. Surg Endosc 2004, 18(2):193-197.
136. Perugini R.A., Mason R., Czerniach D.R., et al. Predictors of complication and suboptimal weight loss after laparoscopic Roux-en-Y gastric bypass: a series of 188 patients. Arch Surg 2003, 138(5):541-545.
137. Phillips B.A., Danner F.J. Cigarette smoking and sleep disturbance. Arch Intern Med 1995, 155(7):734-737.
138. Berry R.B., Desa M.M., Light R.W. Effect of ethanol on the efficacy of nasal continuous positive airway pressure as a treatment for obstructive sleep apnea. Chest 1991, 99(2):339-343.
139. Gleeson K., Zwillich C.W., White D.P. The influence of increasing ventilatory effort on arousal from sleep. Am Rev Respir Dis 1990, 142(2):295-300.
140. Teschler H., Berthon-Jones M., Wessendorf T., et al. Influence of moderate alcohol consumption on obstructive sleep apnoea with and without AutoSet nasal CPAP therapy. Eur Respir J 1996, 9(11):2371-2377.
141. Kohler M., Bloch K.E., Stradling J.R. Pharmacological approaches to the treatment of obstructive sleep apnoea. Expert Opin Investig Drugs 2009, 18(5):647-656.
142. Espinoza H., Antic R., Thornton A.T., et al. The effects of aminophylline on sleep and sleep-disordered breathing in patients with obstructive sleep apnea syndrome. Am Rev Respir Dis 1987, 136(1):80-84.
143. Mulloy E., McNicholas W.T. Theophylline in obstructive sleep apnea. A double-blind evaluation. Chest 1992, 101(3):753-757.
144. Whyte K.F., Gould G.A., Airlie M.A., et al. Role of protriptyline and acetazolamide in the sleep apnea/hypopnea syndrome. Sleep 1988, 11(5):463-472.
145. Atkinson R.L., Suratt P.M., Wilhoit S.C., et al. Naloxone improves sleep apnea in obese humans. Int J Obes 1985, 9(4):233-239.
146. Ferber C., Duclaux R., Mouret J. Naltrexone improves blood gas patterns in obstructive sleep apnoea syndrome through its influence on sleep. J Sleep Res 1993, 2(3):149-155.
147. Cook W.R., Benich J.J., Wooten S.A. Indices of severity of obstructive sleep apnea syndrome do not change during medroxyprogesterone acetate therapy. Chest 1989, 96(2):262-266.
148. Stradling J., Smith D., Radulovacki M., et al. Effect of ondansetron on moderate obstructive sleep apnoea, a single night, placebo-controlled trial. J Sleep Res 2003, 12(2):169-170.
149. Veasey S.C., Chachkes J., Fenik P., et al. The effects of ondansetron on sleep-disordered breathing in the English bulldog. Sleep 2001, 24(2):155-160.
150. Weichler U., Herres-Mayer B., Mayer J., et al. Influence of antihypertensive drug therapy on sleep pattern and sleep apnea activity. Cardiology 1991, 78(2):124-130.
151. Salo T.M., Kantola I., Voipio-Pulkki L.M., et al. The effect of four different antihypertensive medications on cardiovascular regulation in hypertensive sleep apneic patients-assessment by spectral analysis of heart rate and blood pressure variability. Eur J Clin Pharmacol 1999, 55(3):191-198.
152. Salo T.M., Metsala T.H., Kantola I.M., et al. Ramipril Enhances Autonomic Control in Essential Hypertension: A Study Employing Spectral Analysis of Heart Rate Variation. Am J Ther 1994, 1(3):191-197.
153. Bucca C.B., Brussino L., Battisti A., et al. Diuretics in obstructive sleep apnea with diastolic heart failure. Chest 2007, 132(2):440-446.
154. Pimenta E., Gaddam K.K., Oparil S. Mechanisms and treatment of resistant hypertension. J Clin Hypertens (Greenwich) 2008, 10(3):239-244.
155. Ziegler M.G., Milic M., Sun P. Antihypertensive therapy for patients with obstructive sleep apnea. Curr Opin Nephrol Hypertens 2011, 20(1):50-55.
156. Martin R.J., Sanders M.H., Gray B.A., et al. Acute and long-term ventilatory effects of hyperoxia in the adult sleep apnea syndrome. Am Rev Respir Dis 1982, 125(2):175-180.
157. Gold A.R., Schwartz A.R., Bleecker E.R., et al. The effect of chronic nocturnal oxygen administration upon sleep apnea. Am Rev Respir Dis 1986, 134(5):925-929.
158. Sanders M.H., Rogers R.M. Sleep apnea: when does better become benefit?. Chest 1985, 88(3):320-321.
159. Hanly P., Sasson Z., Zuberi N., et al. ST-segment depression during sleep in obstructive sleep apnea. Am J Cardiol 1993, 71(15):1341-1345.
160. Franklin K.A., Nilsson J.B., Sahlin C., et al. Sleep apnoea and nocturnal angina. Lancet 1995, 345(8957):1085-1087.
161. Sanders M.H., Kern N. Obstructive sleep apnea treated by independently adjusted inspiratory and expiratory positive airway pressures via nasal mask. Physiologic and clinical implications. Chest 1990, 98(2):317-324.
162. Piper A.J., Sullivan C.E. Effects of short-term NIPPV in the treatment of patients with severe obstructive sleep apnea and hypercapnia. Chest 1994, 105(2):434-440.
163. Pepin J.L., Viot-Blanc V., Escourrou P., et al. Prevalence of residual excessive sleepiness in CPAP-treated sleep apnoea patients: the French multicentre study. Eur Respir J 2009, 33(5):1062-1067.
164. Morgenthaler T.I., Kapen S., Lee-Chiong T., et al. Practice parameters for the medical therapy of obstructive sleep apnea. Sleep 2006, 29(8):1031-1035.
165. Veasey S.C., Guilleminault C., Strohl K.P., et al. Medical therapy for obstructive sleep apnea: a review by the Medical Therapy for Obstructive Sleep Apnea Task Force of the Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep 2006, 29(8):1036-1044.
166. Black J.E., Hirshkowitz M. Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome. Sleep 2005, 28(4):464-471.
167. Kingshott R.N., Vennelle M., Coleman E.L., et al. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 2001, 163(4):918-923.
168. Pack A.I., Black J.E., Schwartz J.R., et al. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea. Am J Respir Crit Care Med 2001, 164(9):1675-1681.
169. Schwartz J.R., Hirshkowitz M., Erman M.K., et al. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week, open-label study. Chest 2003, 124(6):2192-2199.
170. Roth T., White D., Schmidt-Nowara W., et al. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults. Clin Ther 2006, 28(5):689-706.
171. Hirshkowitz M., Black J.E., Wesnes K., et al. Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome. Respir Med 2007, 101(3):616-627.
172. Hou R.H., Langley R.W., Szabadi E., et al. Comparison of diphenhydramine and modafinil on arousal and autonomic functions in healthy volunteers. J Psychopharmacol 2007, 21(6):567-578.
173. Wong Y.N., Simcoe D., Hartman L.N., et al. A double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers. J Clin Pharmacol 1999, 39(1):30-40.
174. Lavie P., Fischel N., Zomer J., et al. The effects of partial and complete mechanical occlusion of the nasal passages on sleep structure and breathing in sleep. Acta Otolaryngol 1983, 95(1-2):161-166.
175. Suratt P.M., Turner B.L., Wilhoit S.C. Effect of intranasal obstruction on breathing during sleep. Chest 1986, 90(3):324-329.
176. Hoijer U., Ejnell H., Hedner J., et al. The effects of nasal dilation on snoring and obstructive sleep apnea. Arch Otolaryngol Head Neck Surg 1992, 118(3):281-284.
177. Hoffstein V., Mateika S., Metes A. Effect of nasal dilation on snoring and apneas during different stages of sleep. Sleep 1993, 16(4):360-365.
178. Scharf M.B., Brannen D.E., McDannold M. A subjective evaluation of a nasal dilator on sleep & snoring. Ear Nose Throat J 1994, 73(6):395-401.
179. Scharf M.B., McDannold M.D., Zaretsky N.T., et al. Cyclic alternating pattern sequences in non-apneic snorers with and without nasal dilation. Ear Nose Throat J 1996, 75(9):617-619.
180. Cornblatt B., Obuchowski M., Roberts S., et al. Cognitive and behavioral precursors of schizophrenia. Dev Psychopathol 1999, 11(3):487-508.
181. Afzelius L.E., Elmqvist D., Hougaard K., et al. Sleep apnea syndrome-an alternative treatment to tracheostomy. Laryngoscope 1981, 91(2):285-291.
182. Nahmias J.S., Karetzky M.S. Treatment of the obstructive sleep apnea syndrome using a nasopharyngeal tube. Chest 1988, 94(6):1142-1147.
183. Berry R.B., Kryger M.H., Massie C.A. A novel nasal expiratory positive airway pressure (EPAP) device for the treatment of obstructive sleep apnea: a randomized controlled trial. Sleep 2011, 34(4):479-485.
184. Patel A.V., Hwang D., Masdeu M.J., et al. Predictors of response to a nasal expiratory resistor device and its potential mechanisms of action for treatment of obstructive sleep apnea. J Clin Sleep Med 2011, 7(1):13-22.
185. Sullivan C.E., Issa F.G., Berthon-Jones M., et al. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 1981, 1(8225):862-865.
186. Grunstein R.R. Sleep-related breathing disorders. 5. Nasal continuous positive airway pressure treatment for obstructive sleep apnoea. Thorax 1995, 50(10):1106-1113.
187. Grunstein R.R., Hedner J., Grote L. Treatment options for sleep apnoea. Drugs 2001, 61(2):237-251.
188. McDaid C., Duree K.H., Griffin S.C., et al. A systematic review of continuous positive airway pressure for obstructive sleep apnoea-hypopnoea syndrome. Sleep Med Rev 2009, 13(6):427-436.
189. Patel S.R., White D.P., Malhotra A., et al. Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a meta-analysis. Arch Intern Med 2003, 163(5):565-571.
190. Giles T.L., Lasserson T.J., Smith B.H., et al. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev 2006, (3):CD001106.
191. Reeves-Hoche M.K., Hudgel D.W., Meck R., et al. Continuous versus bilevel positive airway pressure for obstructive sleep apnea. Am J Respir Crit Care Med 1995, 151(2 Pt 1):443-449.
192. Fietze I., Glos M., Moebus I., et al. Automatic pressure titration with APAP is as effective as manual titration with CPAP in patients with obstructive sleep apnea. Respiration 2007, 74(3):279-286.
193. Nussbaumer Y., Bloch K.E., Genser T., et al. Equivalence of autoadjusted and constant continuous positive airway pressure in home treatment of sleep apnea. Chest 2006, 129(3):638-643.
194. Zozula R., Rosen R. Compliance with continuous positive airway pressure therapy: assessing and improving treatment outcomes. Curr Opin Pulm Med 2001, 7(6):391-398.
195. Fitzpatrick M.F., Alloway C.E., Wakeford T.M., et al. Can patients with obstructive sleep apnea titrate their own continuous positive airway pressure?. Am J Respir Crit Care Med 2003, 167(5):716-722.
196. Mehta A., Qian J., Petocz P., et al. A randomized, controlled study of a mandibular advancement splint for obstructive sleep apnea. Am J Respir Crit Care Med 2001, 163(6):1457-1461.
197. Gotsopoulos H., Chen C., Qian J., et al. Oral appliance therapy improves symptoms in obstructive sleep apnea: a randomized, controlled trial. Am J Respir Crit Care Med 2002, 166(5):743-748.
198. Cistulli P.A., Gotsopoulos H., Marklund M., et al. Treatment of snoring and obstructive sleep apnea with mandibular repositioning appliances. Sleep Med Rev 2004, 8(6):443-457.
199. Ferguson K.A., Cartwright R., Rogers R., et al. Oral appliances for snoring and obstructive sleep apnea: a review. Sleep 2006, 29(2):244-262.
200. Gagnadoux F., Fleury B., Vielle B., et al. Titrated mandibular advancement versus positive airway pressure for sleep apnoea. Eur Respir J 2009, 34(4):914-920.
201. Hoekema A., Stegenga B., Bakker M., et al. Simulated driving in obstructive sleep apnoea-hypopnoea; effects of oral appliances and continuous positive airway pressure. Sleep Breath 2007, 11(3):129-138.
202. Barnes M., McEvoy R.D., Banks S., et al. Efficacy of positive airway pressure and oral appliance in mild to moderate obstructive sleep apnea. Am J Respir Crit Care Med 2004, 170(6):656-664.
203. Andren A., Sjoquist M., Tegelberg A. Effects on blood pressure after treatment of obstructive sleep apnoea with a mandibular advancement appliance - a three-year follow-up. J Oral Rehabil 2009, 36(10):719-725.
204. Schmidt-Nowara W., Lowe A., Wiegand L., et al. Oral appliances for the treatment of snoring and obstructive sleep apnea: a review. Sleep 1995, 18(6):501-510.
205. Marklund M., Sahlin C., Stenlund H., et al. Mandibular advancement device in patients with obstructive sleep apnea: long-term effects on apnea and sleep. Chest 2001, 120(1):162-169.
206. Marklund M., Stenlund H., Franklin K.A. Mandibular advancement devices in 630 men and women with obstructive sleep apnea and snoring: tolerability and predictors of treatment success. Chest 2004, 125(4):1270-1278.
207. Lim J., Lasserson T.J., Fleetham J., et al. Oral appliances for obstructive sleep apnoea. Cochrane Database Syst Rev 2006, (1). CD004435.
208. Tsuiki S., Kobayashi M., Namba K., et al. Optimal positive airway pressure predicts oral appliance response to sleep apnoea. Eur Respir J 2010, 35(5):1098-1105.
209. Pantin C.C., Hillman D.R., Tennant M. Dental side effects of an oral device to treat snoring and obstructive sleep apnea. Sleep 1999, 22(2):237-240.
210. Rose E.C., Staats R., Virchow C., et al. Occlusal and skeletal effects of an oral appliance in the treatment of obstructive sleep apnea. Chest 2002, 122(3):871-877.
211. Almeida F.R., Lowe A.A., Otsuka R., et al. Long-term sequellae of oral appliance therapy in obstructive sleep apnea patients: part 2. Study-model analysis. Am J Orthod Dentofacial Orthop 2006, 129(2):205-213.
212. Villa M.P., Rizzoli A., Miano S., et al. Efficacy of rapid maxillary expansion in children with obstructive sleep apnea syndrome: 36 months of follow-up. Sleep Breath 2011, 15(2):179-184.
213. Loube D.I., Gay P.C., Strohl K.P., et al. Indications for positive airway pressure treatment of adult obstructive sleep apnea patients: a consensus statement. Chest 1999, 115(3):863-866.
214. Holty J.E., Guilleminault C. Surgical options for the treatment of obstructive sleep apnea. Med Clin North Am 2010, 94(3):479-515.
215. Sundaram S., Bridgman S.A., Lim J., et al. Surgery for obstructive sleep apnoea. Cochrane Database Syst Rev 2005, (4). CD001004.
216. Khan A., Ramar K., Maddirala S., et al. Uvulopalatopharyngoplasty in the management of obstructive sleep apnea: the Mayo clinic experience. Mayo Clin Proc 2009, 84(9):795-800.
217. Mortimore I.L., Bradley P.A., Murray J.A., et al. Uvulopalatopharyngoplasty may compromise nasal CPAP therapy in sleep apnea syndrome. Am J Respir Crit Care Med 1996, 154(6 Pt 1):1759-1762.
218. Riley R., Powell N., Guilleminault C. Maxillofacial surgery and nasal CPAP: a comparison of treatment for obstructive sleep apnea syndrome. Chest 1990, 98:1421-1425.
219. Riley R., Powell N., Guilleminault C. Obstructive sleep apnea syndrome: a review of 306 consecutively treated surgical patients. Otolaryngol Head Neck Surg 1993, 108:117-125.
220. Walker-Engstrom M.L., Tegelberg A., Wilhelmsson B., et al. 4-Year follow-up of treatment with dental appliance or uvulopalatopharyngoplasty in patients with obstructive sleep apnea: a randomized study. Chest 2002, 121(3):739-746.
221. White D.P. Central sleep apnea. Med Clin North Am 1985, 69(6):1205-1219.
222. White D.P. Pathogenesis of obstructive and central sleep apnea. Am J Respir Crit Care Med 2005, 172(11):1363-1370.
223. Badr M.S., Toiber F., Skatrud J.B., et al. Pharyngeal narrowing/occlusion during central sleep apnea. J Appl Physiol 1995, 78(5):1806-1815.
224. Sankri-Tarbichi A.G., Rowley J.A., Badr M.S. Expiratory pharyngeal narrowing during central hypocapnic hypopnea. Am J Respir Crit Care Med 2009, 179(4):313-319.
225. Sankri-Tarbichi A.G., Richardson N.N., Chowdhuri S., et al. Hypocapnia is associated with increased upper airway expiratory resistance during sleep. Respir Physiol Neurobiol 2011, 177(2):108-113.
226. White D.P., Gleeson K., Pickett C.K., et al. Altitude acclimatization: influence on periodic breathing and chemoresponsiveness during sleep. J Appl Physiol 1987, 63(1):401-412.
227. Franklin K.A., Eriksson P., Sahlin C., et al. Reversal of central sleep apnea with oxygen. Chest 1997, 111(1):163-169.
228. Szollosi I., Jones M., Morrell M.J., et al. Effect of CO2 inhalation on central sleep apnea and arousals from sleep. Respiration 2004, 71(5):493-498.
229. Issa F.G., Sullivan C.E. Reversal of central sleep apnea using nasal CPAP. Chest 1986, 90(2):165-171.
230. Hommura F., Nishimura M., Oguri M., et al. Continuous versus bilevel positive airway pressure in a patient with idiopathic central sleep apnea. Am J Respir Crit Care Med 1997, 155(4):1482-1485.
231. Quadri S., Drake C., Hudgel D.W. Improvement of idiopathic central sleep apnea with zolpidem. J Clin Sleep Med 2009, 5(2):122-129.
232. DeBacker W.A., Verbraecken J., Willemen M., et al. Central apnea index decreases after prolonged treatment with acetazolamide. Am J Respir Crit Care Med 1995, 151(1):87-91.
233. Javaheri S., Parker T.J., Liming J.D., et al. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 1998, 97(21):2154-2159.
234. Sin D.D., Fitzgerald F., Parker J.D., et al. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 1999, 160(4):1101-1106.
235. Bradley T.D., Logan A.G., Kimoff R.J., et al. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 2005, 353(19):2025-2033.
236. Arzt M., Floras J.S., Logan A.G., et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation 2007, 115(25):3173-3180.
237. Teschler H., Dohring J., Wang Y.M., et al. Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure. Am J Respir Crit Care Med 2001, 164(4):614-619.
238. Allam J.S., Olson E.J., Gay P.C., et al. Efficacy of adaptive servoventilation in treatment of complex and central sleep apnea syndromes. Chest 2007, 132(6):1839-1846.
239. Pepperell J.C., Maskell N.A., Jones D.R., et al. A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure. Am J Respir Crit Care Med 2003, 168(9):1109-1114.
240. Philippe C., Stoica-Herman M., Drouot X., et al. Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period. Heart 2006, 92(3):337-342.
241. Novak S., Nemeth W.C., Lawson K.A. Trends in medical use and abuse of sustained-release opioid analgesics: a revisit. Pain Med 2004, 5(1):59-65.
242. Teichtahl H., Prodromidis A., Miller B., et al. Sleep-disordered breathing in stable methadone programme patients: a pilot study. Addiction 2001, 96(3):395-403.
243. Wang D., Teichtahl H., Drummer O., et al. Central sleep apnea in stable methadone maintenance treatment patients. Chest 2005, 128(3):1348-1356.
244. Walker J.M., Farney R.J., Rhondeau S.M., et al. Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing. J Clin Sleep Med 2007, 3(5):455-461.
245. Webster L.R., Choi Y., Desai H., et al. Sleep-disordered breathing and chronic opioid therapy. Pain Med 2008, 9(4):425-432.
246. Javaheri S., Malik A., Smith J., et al. Adaptive pressure support servoventilation: a novel treatment for sleep apnea associated with use of opioids. J Clin Sleep Med 2008, 4(4):305-310.
247. Grunstein R.R., Ho K.Y., Berthon-Jones M., et al. Central sleep apnea is associated with increased ventilatory response to carbon dioxide and hypersecretion of growth hormone in patients with acromegaly. Am J Respir Crit Care Med 1994, 150(2):496-502.
248. Weiss V., Sonka K., Pretl M., et al. Prevalence of the sleep apnea syndrome in acromegaly population. J Endocrinol Invest 2000, 23(8):515-519.
249. Tolis G., Angelopoulos N.G., Katounda E., et al. Medical treatment of acromegaly: comorbidities and their reversibility by somatostatin analogs. Neuroendocrinology 2006, 83(3-4):249-257.
250. Grunstein R.R., Ho K.K., Sullivan C.E. Effect of octreotide, a somatostatin analog, on sleep apnea in patients with acromegaly. Ann Intern Med 1994, 121(7):478-483.
251. Sze L., Schmid C., Bloch K.E., et al. Effect of transsphenoidal surgery on sleep apnoea in acromegaly. Eur J Endocrinol 2007, 156(3):321-329.
252. Pekkarinen T., Partinen M., Pelkonen R., et al. Sleep apnoea and daytime sleepiness in acromegaly: relationship to endocrinological factors. Clin Endocrinol (Oxf) 1987, 27(6):649-654.
253. Pelttari L., Polo O., Rauhala E., et al. Nocturnal breathing abnormalities in acromegaly after adenomectomy. Clin Endocrinol (Oxf) 1995, 43(2):175-182.
254. de Oliveira Rodrigues C.J., Marson O., Tufic S., et al. Relationship among end-stage renal disease, hypertension, and sleep apnea in nondiabetic dialysis patients. Am J Hypertens 2005, 18(2 Pt 1):152-157.
255. Tada T., Kusano K.F., Ogawa A., et al. The predictors of central and obstructive sleep apnoea in haemodialysis patients. Nephrol Dial Transplant 2007, 22(4):1190-1197.
256. Beecroft J.M., Hoffstein V., Pierratos A., et al. Nocturnal haemodialysis increases pharyngeal size in patients with sleep apnoea and end-stage renal disease. Nephrol Dial Transplant 2008, 23(2):673-679.
257. Beecroft J.M., Duffin J., Pierratos A., et al. Decreased chemosensitivity and improvement of sleep apnea by nocturnal hemodialysis. Sleep Med 2009, 10(1):47-54.
258. Beecroft J., Duffin J., Pierratos A., et al. Enhanced chemo-responsiveness in patients with sleep apnoea and end-stage renal disease. Eur Respir J 2006, 28(1):151-158.
259. Hamilton R.W., Epstein P.E., Henderson L.W., et al. Control of breathing in uremia: ventilatory response to CO2 after hemodialysis. J Appl Physiol 1976, 41(2):216-222.
260. Wilcox I., McNamara S.G., Dodd M.J., et al. Ventilatory control in patients with sleep apnoea and left ventricular dysfunction: comparison of obstructive and central sleep apnoea. Eur Respir J 1998, 11(1):7-13.
261. Jean G., Piperno D., Francois B., et al. Sleep apnea incidence in maintenance hemodialysis patients: influence of dialysate buffer. Nephron 1995, 71(2):138-142.
262. Langevin B., Fouque D., Leger P., et al. Sleep apnea syndrome and end-stage renal disease. Cure after renal transplantation. Chest 1993, 103(5):1330-1335.
263. Beecroft J.M., Zaltzman J., Prasad R., et al. Impact of kidney transplantation on sleep apnoea in patients with end-stage renal disease. Nephrol Dial Transplant 2007, 22(10):3028-3033.
264. Morgenthaler T.I., Kagramanov V., Hanak V., et al. Complex sleep apnea syndrome: is it a unique clinical syndrome?. Sleep 2006, 29(9):1203-1209.
265. Dernaika T., Tawk M., Nazir S., et al. The significance and outcome of continuous positive airway pressure-related central sleep apnea during split-night sleep studies. Chest 2007, 132(1):81-87.
266. Lehman S., Antic N.A., Thompson C., et al. Central sleep apnea on commencement of continuous positive airway pressure in patients with a primary diagnosis of obstructive sleep apnea-hypopnea. J Clin Sleep Med 2007, 3(5):462-466.
267. Kuzniar T.J., Pusalavidyasagar S., Gay P.C., et al. Natural course of complex sleep apnea-a retrospective study. Sleep Breath 2008, 12(2):135-139.
268. Morgenthaler T.I., Gay P.C., Gordon N., et al. Adaptive servoventilation versus noninvasive positive pressure ventilation for central, mixed, and complex sleep apnea syndromes. Sleep 2007, 30(4):468-475.
269. Javaheri S., Smith J., Chung E. The prevalence and natural history of complex sleep apnea. J Clin Sleep Med 2009, 5(3):205-211.
270. Endo Y., Suzuki M., Inoue Y., et al. Prevalence of complex sleep apnea among Japanese patients with sleep apnea syndrome. Tohoku J Exp Med 2008, 215(4):349-354.
271. Aurora R.N., Chowdhuri S., Ramar K., et al. The treatment of central sleep apnea syndromes in adults: practice parameters with an evidence-based literature review and meta-analyses. Sleep 2012, 35(1):17-40.
272. Littleton S.W., Mokhlesi B. The pickwickian syndrome-obesity hypoventilation syndrome. Clin Chest Med 2009, 30(3):467-478. viii.
273. Mokhlesi B., Kryger M.H., Grunstein R.R. Assessment and management of patients with obesity hypoventilation syndrome. Proc Am Thorac Soc 2008, 5(2):218-225.
274. Mokhlesi B., Tulaimat A., Faibussowitsch I., et al. Obesity hypoventilation syndrome: prevalence and predictors in patients with obstructive sleep apnea. Sleep Breath 2007, 11(2):117-124.
275. Lin C.C., Wu K.M., Chou C.S., et al. Oral airway resistance during wakefulness in eucapnic and hypercapnic sleep apnea syndrome. Respir Physiol Neurobiol 2004, 139(2):215-224.
276. Piper A.J., Grunstein R.R. Big breathing: the complex interaction of obesity, hypoventilation, weight loss, and respiratory function. J Appl Physiol 2010, 108(1):199-205.
277. Sharp J.T., Henry J.P., Sweany S.K., et al. The total work of breathing in normal and obese men. J Clin Invest 1964, 43:728-739.
278. Koenig S.M. Pulmonary complications of obesity. Am J Med Sci 2001, 321(4):249-279.
279. Lopata M., Freilich R.A., Onal E., et al. Ventilatory control and the obesity hypoventilation syndrome. Am Rev Respir Dis 1979, 119(2 Pt 2):165-168.
280. Lopata M., Onal E. Mass loading, sleep apnea, and the pathogenesis of obesity hypoventilation. Am Rev Respir Dis 1982, 126(4):640-645.
281. Han F., Chen E., Wei H., et al. Zhonghua Nei Ke Za Zhi 1999, 38(7):466-469. [in Chinese].
282. Bradley C.A., Fleetham J.A., Anthonisen N.R. Ventilatory control in patients with hypoxemia due to obstructive lung disease. Am Rev Respir Dis 1979, 120(1):21-30.
283. Kaw R., Hernandez A.V., Walker E., et al. Determinants of hypercapnia in obese patients with obstructive sleep apnea: a systematic review and metaanalysis of cohort studies. Chest 2009, 136(3):787-796.
284. Kaltman A.J., Goldring R.M. Role of circulatory congestion in the cardiorespiratory failure of obesity. Am J Med 1976, 60(5):645-653.
285. Crummy F., Piper A.J., Naughton M.T. Obesity and the lung: 2. Obesity and sleep-disordered breathing. Thorax 2008, 63(8):738-746.
286. Piper A.J., Grunstein R.R. Obesity hypoventilation syndrome: mechanisms and management. Am J Respir Crit Care Med 2011, 183(3):292-298.
287. Phipps P.R., Starritt E., Caterson I., et al. Association of serum leptin with hypoventilation in human obesity. Thorax 2002, 57(1):75-76.
288. Yee B.J., Cheung J., Phipps P., et al. Treatment of obesity hypoventilation syndrome and serum leptin. Respiration 2006, 73(2):209-212.
289. Kalra S.P. Central leptin insufficiency syndrome: an interactive etiology for obesity, metabolic and neural diseases and for designing new therapeutic interventions. Peptides 2008, 29(1):127-138.
290. Sugerman H.J., Fairman R.P., Lindeman A.K., et al. Gastroplasty for respiratory insufficiency of obesity. Ann Surg 1981, 193(6):677-685.
291. Sugerman H.J., Fairman R.P., Sood R.K., et al. Long-term effects of gastric surgery for treating respiratory insufficiency of obesity. Am J Clin Nutr 1992, 55(Suppl 2):597S-601S.
292. Sugerman H.J. Bariatric surgery for severe obesity. J Assoc Acad Minor Phys 2001, 12(3):129-136.
293. Olson A.L., Zwillich C. The obesity hypoventilation syndrome. Am J Med 2005, 118(9):948-956.
294. Perez de Llano L.A., Golpe R., Ortiz P.M., et al. Short-term and long-term effects of nasal intermittent positive pressure ventilation in patients with obesity-hypoventilation syndrome. Chest 2005, 128(2):587-594.
295. Mokhlesi B. Positive airway pressure titration in obesity hypoventilation syndrome: continuous positive airway pressure or bilevel positive airway pressure. Chest 2007, 131(6):1624-1626.
296. Berry R.B., Chediak A., Brown L.K., et al. Best clinical practices for the sleep center adjustment of noninvasive positive pressure ventilation (NPPV) in stable chronic alveolar hypoventilation syndromes. J Clin Sleep Med 2010, 6(5):491-509.
297. Perez de Llano L.A., Golpe R., Piquer M.O., et al. Clinical heterogeneity among patients with obesity hypoventilation syndrome: therapeutic implications. Respiration 2008, 75(1):34-39.
298. Storre J.H., Seuthe B., Fiechter R., et al. Average volume-assured pressure support in obesity hypoventilation: a randomized crossover trial. Chest 2006, 130(3):815-821.
299. Wijesinghe M., Williams M., Perrin K., et al. The effect of supplemental oxygen on hypercapnia in subjects with obesity-associated hypoventilation: a randomized, crossover, clinical study. Chest 2011, 139(5):1018-1024.
300. Hensley M.J., Read D.J. Intemittent obstruction of the upper airway during sleep causing profound hypoxaemia. A neglected mechanism exacerbating chronic respiratory failure. Aust N Z J Med 1976, 6(5):481-486.